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A B S T R A C T Human umbilical arteries are unique vessels in that they close quickly and completely at birth. It has been suggested that cyclic guanosine 3',5'-monophosphate (cGMP) plays a role in smooth muscle contraction and cyclic adenosine 3',5'-monophosphate (cAMP) in relaxation. This hypothesis has been evaluated in term gestational human umbilical artery segments incubated at 370C and in room air. (a) The basal cGMP content (1 pmol/mg protein) of artery segments incubated in room air was almost twice that of cAMP.
(b) Bradykinin, histamine, serotonin, acetylcholine, and Ki ion, which cause umbilical artery constriction, can increase the cGMP content of the artery segments within 30 s of exposure without altering the cAMP content. (c) Prostaglandin Ei, but not isoproterenol, caused accumulation of cAMP which is consistent with reports that umbilical arteries lack functional P-receptors and that only prostaglandin E1 can bring about relaxation of umbilical arteries. (d) 1 AM atropine blocked the effect of 100 FM acetylcholine on cGMP content without altering the responses to histamine, bradykinin, serotonin, or K' ion. (e) Pyrilamine (an H1 antagonist), but not metiamide (an H2 antagonist), blocked the effect of histamine on cGMP from which it is inferred that histamine causes accumulation of cGMP in umbilical artery via its interaction with Hi receptors. The results are consistent with the view that metabolism of the two cyclic nucleotides is independently controlled in the human umbilical artery and that cGMP is involved in contraction of the artery at birth.
INTRODUCTION
Umbilical arteries are unique blood vessels in the sense that they must remain patent in utero but most close completely and relatively quickly after delivery. The precise mechanism for the spontaneous closure of the umbilical vessels at birth is unknown. The importance of neurogenic mechanisms may be questionable, since it is thought that umbilical arteries are either not innervated (1) or are associated with only a scanty supply of nerve elements (2) .
It is generally believed that humoral agents or oxygen or both are the stimuli that initiate closure of umbilical arteries. The artery in vitro constricts when exposed to oxygen (3) (4) (5) (6) . In addition, by virtue of their ability to produce constriction in vitro as well as their actual or presumed concentrations in cord blood at birth, bradykinin, serotonin, histamine, acetylcholine, prostaglandins A2 and F2 have been suggested as probable chemical mediators of umbilical artery closure (4) (5) (6) (7) (8) (9) (10) . Several of these agents have been reported to cause accumulation of cyclic guanosine 3',5'-monophosphate (cGMP)1 in other tissues (11) (12) (13) (14) (15) (16) . We have found, as reported below, that bradykinin, histamine, serotonin, and acetylcholine, as well as potassium chloride, in concentrations that cause contraction (4, 6) , can increase the cGMP content of the arteries without altering the cAMP content. Accumulation of cAMP was induced by prostaglandin E1 (PGE1) but not by isoproterenol.
These observations are consistent with earlier reports that umbilical arteries lack functional P-adrenergic receptors (4, 7) and that PGE1, but not isoproterenol, can bring about dilatation or relaxation of umbilical arteries (9) .
METHODS
Human umbilical cords from normal full-term deliveries were obtained within 30 min of delivery. Both arteries were dissected and prepared for incubation within 2 h.
Hanks' medium at room temperature was used for these procedures. As preliminary studies revealed no difference in effects of various agonists on the cGMP content of arterial segments taken from placental, midcord, and infant thirds of the same artery, the entire length of the artery, except for 5 cm at either end, was used. The arteries were opened longitudinally, divided into 0.5-cm segments which were randomly assigned to 25- (17) with bovine serum albumin as a standard. Protein content was 4.5-5.5% of wet tissue weight.
After the addition of [8H]cGMP (<1 pmol) to each, supernates were neutralized with 50% KOH and centrifuged. The supernates were applied to columns (0.5 X 3 cm) of neutral alumina which had previously been washed with 10 ml 5 mM Tris-HCl buffer, pH 7.4, and followed by 6 ml of the same buffer. The resulting eluates were applied to columns (0.5 X 3 cm) of AG 1-X8 formate which were then washed with 20 ml of 0.5 N formic acid before elution of cGMP with 10 ml of 4 N formic acid. The eluates were lyophilized, and the residues dissolved in 500 A of 50 mM sodium acetate buffer, pH 6.2, with 1.6 mM MgCl,. Samples were taken for determination of recovery of [8H]cGMP which ranged from 45 to 65% and for radioimmunoassay of cGMP (18) .
For each concentration point on the standard curve, we carried a sample of incubation medium plus perchloric acid through the purification process used for the tissue extracts. These lyophilized residues were dissolved in 500 ,ul buffer, and an appropriate standard of cGMP was added to each. Samples of unknowns and of these cGMP standards were incubated with labeled antigen and antibody in 50 mM sodium acetate, pH 6.2, with 1.6 mM MgC12 at 40C for [16] [17] [18] [19] [20] [21] [22] [23] [24] h. 500 ug Rabbit serum 'y-globulin (19) was then added to each sample and the bound antigen precipitated with ammonium sulfate (final concentration equal to 30 g/100 ml). After centrifugation at 1,500 g for 45 min, the supernates were decanted. The precipitates were washed again with ammonium sulfate solution before assay of 'I in a Packard Auto Gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). This procedure yielded reproducible standard curves with linear titration from 0.2 to 20 pmol of cGMP. Incubation of samples from representative experiments with cyclic 3',5'-nucleotide phosphodiesterase before assay produced 100% hydrolysis of cGMP in all cases.
For cAMP experiments, incubations were carried out as described and cAMP was purified as previously described (20) for assay by the method of Gilman (21) .
[ Fig. 1 , within 0.5 min after the addition of 100 AM acetylcholine, 1 iM histamine, or 1.1,IM bradykinin to the artery segments, marked accumulation of cGMP had occurred. Maximal accumulation of cGMP was attained within 2 min of exposure to the agonist. The effect of histamine was apparently sustained for at least 10 min, but those of acetylcholine and bradykinin decreased after 2 min. In further studies with these and other agents, a 2-min period of exposure was used.
In the experiments shown in Fig. 1 , it is obvious that the effects of the three agonists differed greatly in magnitude, and there were also large differences in the effects produced by any one of them on different arteries (Fig. 2) . The mean increments in cGMP produced by 1.1 AM bradykinin and 1 gM histamine were, however, greater than those of acetylcholine or serotonin (Fig. 2) . In addition, when effects of two or more of the agonists were compared in any single experiment, those of 1.1 'M bradykinin and 1 AM histamine tended to be similar and consistently greater than those of 100 'M acetylcholine or 10 IM serotonin. In the experiment shown in Fig. 3 Fig. 1 . For the latter, segments of artery were incubated for 2 h in 2.5 ml of Krebs-Ringer-Tris medium containing 5 mM K+ ion. 5 ml of Krebs-Ringer-Tris medium containing 132 mM K+ ion (KCl replaced NaCl) at 370C was then added to yield a final concentration of 90 mM K+ ion and the incubation was terminated 2 min later.
As shown in Fig. 2 , when the K+ ion concentration of the medium was raised from 5 to 90 mM, significant accumulation of cGMP occurred within 2 min. The effect of K+ ion was less than that of bradykinin or histamine and was similar in magnitude to that of acetylcholine or serotonin. Prostaglandins Ei, A2, and F2u (5 /g/ml) and isoproterenol (1 or 10 iOM) had no effects on the cGMP content of artery segments.
The effect of 100 ,gM acetylcholine on cGMP accumulation was completely prevented by 1 ttM atropine which was without significant effect when added alone or in FIGURE 5 Effect of PGE1 on the time course of cAMP accumulation in human umbilical artery. See Fig. 4 for explanation. Segments of the same artery were exposed to PGE1 (5 ,ug/ml), 14 uM for varying periods of time.
fact, at the higher concentrations (50 and 100 MM) metiamide slightly increased basal cGMP content.
The cAMP content of 10 artery preparations incubated for 2 h was 0.67±0.09 pmol/mg protein (mean± SEM), i.e., lower than the cGMP content of this tissue. In an attempt to magnify the effects of agents that might cause accumulation of cAMP, 1 mM theophylline which did not significantly alter basal levels of cAMP was present in the medium for these experiments. As shown in Fig. 5 , after 1 min of exposure of artery segments to 14 MM PGE, (5 Mg/ml), marked accumulation of cAMP had occurred. The effect of PGE1 which was apparently maximal at 3 min was maintained for at least 15 min. In six experiments incubation for 3 min with 14 MM PGE,, a maximally effective concentration (Fig. 6) , increased the cAMP content of the artery (plus medium) by 1.66±0.45 pmol/mg protein (mean of paired differences±SEM, P < 0.01). 0.5% ethanol, the highest concentration present in incubations with PGEi, had no effect.
In other experiments, and in medium containing 1 mM theophylline, isoproterenol (1 or 10 FM) as well as 10 ALM serotonin, 1 AM bradykinin, 1 FM histamine, 100 FM acetylcholine, and 90 mM K+ ion were without effect on arterial cAMP content.
DISCUSSION
It has been suggested that cGMP plays a role in smooth muscle contraction and cAMP in relaxation (22) . In the umbilical artery, the concentrations of the two cyclic nucleotides appear to be independently controlled in a manner that correlates with and mirrors the contractile behavior of the tissue. Triner, Vulliemoz, Verosky, Habif, and Nahas (23) found that in aortic strips P-adrenergic stimulation produced an increase in cAMP content as well as muscle relaxation. Because of the failure of isoproterenol to cause dilation of umbilical arteries (4, 7) and to cause accumulation of cAMP in our studies, it may be inferred that P-receptors either are lacking in this tissue or, if present, are not functionally linked to adenylate cyclase. Of all of the agents studied, only PGE1 is reported to cause relaxation of the umbilical artery (9) , and, similarly, only PGE, caused accumulation of cAMP in this tissue.
The functional significance of the finding that the cGMP content of the term umbilical artery (1 pmol/mg protein) incubated at room air is almost twice that of cAMP remains obscure. In all other mammalian tissues thus far studied, the cAMP concentration is greater than, in some cases 100 times, that of cGMP (22) . Perhaps the relatively high cGMP content of the umbilical artery at term and in room air is related to the physiological importance of arterial contraction under these conditions. Umbilical artery constriction can be induced by acetylcholine, histamine, bradykinin, serotonin, and a high concentration of K+ ion as well as by PGAS and PGF2. (6) . Of these only PGA2 and PGF2 failed in our experiments to cause accumulation of cGMP. None of them altered the cAMP content of the tissue. The concentrations of the respective agonists required to produce maximal effects on cGMP are similar to those that have been reported to cause maximal contraction of the artery in vitro (4, 6) . In several tissues the effect of acetylcholine on cGMP content is apparently mediated through a muscarinic receptor (11) (12) (13) (14) , and in the umbilical artery it was prevented by atropine, which did not alter the responses to histamine, bradykinin, or serotonin. The effects of histamine but not those of the other agonists were inhibited by pyrilamine. The suggestive (but not statistically significant) inhibition by pyrilamine of the responses to acetylcholine and serotonin may be related in the first case to the anticholinergic properties of most antihistamines and in the second to the observation (24) that effects of serotonin on smooth muscle can be inhibited by antihistamines of the ethylenediamine class, e.g., pyrilamine.
Ash and Schild (25) have postulated at least two types of histamine receptors. Interaction of histamine with H1 receptors causes vasodilation and smooth muscle contraction, whereas histamine acting through H2 receptors stimulates gastric acid secretion, elevates heart rate, relaxes uterine smooth muscle and increases the cAMP content of gastric mucosa and leukocytes (26, 27) . Pyrilamine, an H1 antagonist, which abolished the effect of histamine on cGMP accumulation in the umbilical artery, also prevents histamine-induced contraction in this tissue (6) . Metiamide, an H2 antagonist, did not interfere with the effect of 1/tM histamine on cGMP in the umbilical artery.' Thus it appears that histamine causes accumulation of cGMP in umbilical artery via its interaction with H1 receptors. There is no evidence that it can, through H2 receptors, activate adenylate cyclase in this tissue.
Thus in the umbilical artery as in certain other tissues containing smooth muscle, chemical agents that produce contraction also cause accumulation of cGMP and those that induce relaxation increase the concentration of cAMP. PGE1 presumably increases cAMP in the umbilical artery by causing activation of adenylate cyclase as it does in other tissues. Whether histamine, acetylcholine, bradykinin, serotonin and K+ ions elevate cGMP as a consequence of increasing (directly or indirectly) synthesis of the nucleotide or decreasing degradation remains to be established.
Because of the cellular heterogeneity of the artery, it is difficult to prove that the changes in cyclic nucleotide content do, in fact, occur in the muscle. For this reason, studies with homogeneous populations of cultured arterial smooth muscle cells, as well as with the umbilical artery, are now in progress to evaluate further the role of cGMP in the contraction produced by acetylcholine, histamine, serotonin, bradykinin, and K+ as well as by other factors (e.g. oxygen) that have been implicated in the induction of umbilical artery closure at birth.
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